Related Experiment Videos

A mutation in the transforming growth factor beta type II receptor gene promoter associated with loss of gene

T Muñoz-Antonia1, X Li, M Reiss

  • 1Cancer Cell Biology Program, H.L. Moffitt Cancer Center, University of South Florida School of Medicine, Tampa 33612, USA.

Cancer Research
|November 1, 1996
PubMed

Insights

Loss of transforming growth factor beta type II receptors (TbetaR-IIs) is linked to tumor development. A specific gene mutation was found to decrease TbetaR-II expression, contributing to squamous carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Transforming growth factor beta type II receptors (TbetaR-IIs) play a crucial role in cellular processes.
  • Reduced or absent TbetaR-II expression is observed in numerous tumors, suggesting its involvement in tumorigenesis.

Purpose of the Study:

  • To investigate the expression of TbetaR-II in a squamous carcinoma cell line with diminished TbetaR-II mRNA levels.
  • To identify the molecular mechanisms underlying the reduced TbetaR-II expression in this specific tumor context.

Main Methods:

  • Analysis of TbetaR-II receptor expression in a squamous carcinoma cell line.
  • Identification and characterization of mutations within the TbetaR-II gene, specifically in the 5' untranslated region.
  • Assessment of the impact of identified mutations on TbetaR-II gene promoter activity and transcriptional levels.

Main Results:

  • A specific mutation (A --> G) was identified at position -364 in the 5' untranslated region of the TbetaR-II gene.
  • This mutation was found to significantly decrease the transcriptional activity of the TbetaR-II gene promoter.
  • The identified mutation provides a molecular explanation for the reduced TbetaR-II expression observed in the studied tumor cell line.

Conclusions:

  • The loss of TbetaR-II function is a significant factor in tumor development.
  • A specific mutation in the TbetaR-II gene's 5' untranslated region can lead to decreased receptor expression.
  • This genetic alteration represents a primary mechanism for TbetaR-II downregulation in certain squamous carcinomas.

Related Concept Videos